金城医药：控股子公司药品注射用头孢呋辛钠获药品补充申请批准通知书

Core Viewpoint - Jincheng Pharmaceutical (300233) announced the approval of a supplemental application for injectable Cefuroxime Sodium by the National Medical Products Administration, indicating a significant development in its product portfolio [1] Group 1: Product Approval - The approved drug, injectable Cefuroxime Sodium, is primarily used for treating infections caused by bacteria sensitive to Cefuroxime, including respiratory and ENT infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, and bone and joint infections [1]